[37]
|
Human
|
6
|
Ag NPs/ carboxyl or PEG
|
2–15 or 5–15b
|
40 or 75 μg/mLc/ 6 h
|
spICP-MS
|
Bright-field light microscopy
|
Higher transplacental transport for smaller and PEGylated Ag NPs, while carboxylated Ag NPs accumulated more in placental tissue.
|
[31]
|
Human
|
6
|
Au NPs/ carboxyl or PEG
|
3.5 ± 1.2 or 4.5 ± 1.5b
|
25 μg/mLc/ 6 h
|
LA- and SF-ICP-MS
|
/
|
Only PEGylated Au NPs observed in the fetal circulation. Placental tissue accumulation similar for both Au NP types.
|
[38]
|
Rat
|
11
|
Au NPs
|
20a
|
5.8 μg/mLd/ 3 h
|
ICP-MS
|
Hyper-spectral microscopy imaging
|
Au NPs translocated across the rat placenta within 20 min of maternal infusion.
|
[23]
|
Human
|
n.d.
|
Au NPs/ PEG
|
15 or 30a
|
1.6 × 1011 or 1.6 × 1010 particles/mLd/ 18 min
|
ICP-MS
|
TEM and bright-field light microscopy
|
No placental transfer of Au NPs detected. Visual confirmation of localization of NPs in syncytiotrophoblasts.
|
[23]
|
Human
|
n.d.
|
Au NPs/ PEG
|
10 or 15a
|
9.1 × 109 or 2.0 × 109 particles/mLc/ 6 h
|
ICP-MS
|
TEM and bright-field light microscopy
|
No transfer of Au NPs across placenta regardless of NP size. Visual confirmation of placental tissue uptake of Au NPs.
|
[25]
|
Human
|
6
|
SiO2 NPs/ fluorophore
|
25 or 50a
|
100 μg/mLc/ 6 h
|
Fluorescence microscopy
|
Confocal microscopy
|
Limited transfer of both SiO2 NP sizes to fetal perfusate despite placental accumulation.
|
[39]
|
Human
|
n.d.
|
Magnetic NPs/ starch or PEI
|
100 or 150a
|
50 μg/mLc/ 6 h
|
Magnetic system
|
Bright-field light microscopy
|
Limited transfer of magnetic NPs from the maternal to the fetal circuit. Histological findings confirmed the presence of NPs in placental tissue.
|
[34]
|
Human
|
6
|
TiO2 NPs/ amine or carboxyl
|
4 to 8a
|
10 μg/mLc/ 6 h
|
SF-ICP-MS
|
/
|
No translocation of both TiO2 NP types to the fetal circulation but accumulation in placental tissue.
|
[40]
|
Human
|
7
|
PS NPs/ fluorophore
|
80 or 500a
|
25 μg/mLc/ 6 h
|
Fluorescence microscopy
|
/
|
80 nm PS NPs able to cross the placenta, while 500 nm PS NPs retained in the placenta or maternal circuit.
|
[41]
|
Human
|
12
|
PS NPs/ fluorophore and carboxyl
|
43.7 ± 8, 44.1 ± 7.1, 220.5 ± 5.1, or 289.4 ± 10.2b
|
25 μg/mLe/ 6 h
|
Fluorescence microscopy
|
TEM
|
Increased translocation of plain compared to carboxylated PS NPs after 6 h of perfusion. Significantly higher transfer of NPs in the fetal to maternal direction observed with bidirectional transfer studies. Placental accumulation of all NPs regardless of modification and perfusion direction.
|
[42]
|
Human
|
32
|
PS NPs/ fluorophore, amine, or carboxyl
|
63 ± 10, 71 ± 11, 78 ± 20, 88 ± 7, 89 ± 3, 181 ± 11, 224 ± 17, 455 ± 32, 451 ± 28, 494 ± 29, or 499 ± 8b
|
25 μg/mLc/ 6 h
|
Fluorescence microscopy
|
/
|
Plain and small carboxylated PS NPs but not aminylated PS NPs transferred across the placenta after 6 h of perfusion.
|
[43]
|
Human
|
16
|
PS NPs/ fluorophore
|
50, 80, 240, or 500a
|
25 μg/mLc/ 6 h
|
/
|
TEM
|
PS NPs up to 240 nm crossed the placenta and reached the fetal circuit. 500 nm PS NPs mainly retained in the placental tissue and maternal circuit.
|